XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Stock Option Activity (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Share-Based Payment Arrangement, Employee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Outstanding, Beginning of Period | shares 2,408,438
Weighted Average Exercise Price Outstanding, Beginning of Period | $ / shares $ 2.50
Weighted Average Remaining Contracted Term (years) Outstanding 8 years 8 months 12 days
Aggregate Intrinsic Value Outstanding, Beginning of Period | $
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Aggregate Intrinsic Value, Granted | $
Number of Options, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Aggregate Intrinsic Value, Forfeited | $
Number of Options, Expired | shares
Weighted Average Exercise Price, Expired | $ / shares
Aggregate Intrinsic Value, Expired | $
Number of Options Outstanding, Ending of Period | shares 2,408,438
Weighted Average Exercise Price Outstanding, End of Period | $ / shares $ 2.50
Weighted Average Remaining Contracted Term (years) Outstanding 8 years 8 months 12 days
Aggregate Intrinsic Value Outstanding, Ending of Period | $
Number of Options, Vested and Expected to Vest | shares 2,141,772
Weighted Average Exercise Price, Vested and Expected to Vest | $ / shares $ 1.83
Weighted Average Remaining Contracted Term (years), Vested and Expected to Vest 6 years 10 months 20 days
Aggregate Intrinsic Value, Vested and Expected to Vest | $
Number of Options Exercisable, End of Period | shares 2,141,772
Weighted Average Exercise Price Exercisable, Ending of Period | $ / shares $ 1.83
Weighted Average Remaining Contracted Term (years), Exercisable at End of Period 6 years 10 months 20 days
Aggregate Intrinsic Value, Exercisable at End of Period | $
Share-Based Payment Arrangement, Nonemployee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Outstanding, Beginning of Period | shares 885,055
Weighted Average Exercise Price Outstanding, Beginning of Period | $ / shares $ 2.02
Weighted Average Remaining Contracted Term (years) Outstanding 9 years 2 months 23 days
Aggregate Intrinsic Value Outstanding, Beginning of Period | $
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Number of Options, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Aggregate Intrinsic Value, Forfeited | $
Number of Options, Expired | shares
Weighted Average Exercise Price, Expired | $ / shares
Number of Options Outstanding, Ending of Period | shares 885,055
Weighted Average Exercise Price Outstanding, End of Period | $ / shares $ 2.02
Weighted Average Remaining Contracted Term (years) Outstanding 9 years 2 months 23 days
Aggregate Intrinsic Value Outstanding, Ending of Period | $  
Number of Options, Vested and Expected to Vest | shares 640,055
Weighted Average Exercise Price, Vested and Expected to Vest | $ / shares $ 2.27
Weighted Average Remaining Contracted Term (years), Vested and Expected to Vest 10 years 14 days
Aggregate Intrinsic Value, Vested and Expected to Vest | $
Number of Options Exercisable, End of Period | shares 640,055
Weighted Average Exercise Price Exercisable, Ending of Period | $ / shares $ 2.27
Weighted Average Remaining Contracted Term (years), Exercisable at End of Period 10 years 14 days
Aggregate Intrinsic Value, Expired | $